Skip to content
Research Article Open access CC BY 4.0

The Intersection of Hepcidin and Polycystic Ovary Syndrome: A Review of Current Understanding

Athira PR, Swathi. D, Sukesh, Ajita Pillai, Delna N.S

Asian Journal of Medicine and Health · pp. 174–181 · Published 24 Jun 2024

10.9734/ajmah/2024/v22i71058

Abstract

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting up to 13% of reproductive-age women. It is characterized by a constellation of symptoms including menstrual irregularities, hyperandrogenism, and polycystic ovaries, often intertwined with metabolic disturbances such as insulin resistance and dyslipidemia. Hepcidin is a liver-produced peptide hormone that regulates iron homeostasis, with a significant role in the pathophysiology of PCOS. Hepcidin controls iron absorption and storage by binding to ferroportin, leading to its degradation and reducing iron export from enterocytes and macrophages. In PCOS patients, hepcidin dysregulation is linked to underlying hormonal and metabolic abnormalities, including insulin resistance and hyperandrogenism. Studies consistently demonstrate decreased hepcidin levels in PCOS patients, resulting in altered iron metabolism parameters, such as increased serum iron and ferritin concentrations, leading to iron overload. This iron overload can exacerbate complications like anemia. The relationship between hepcidin, anemia, and PCOS is influenced by several mechanisms. Hyperandrogenism in PCOS inhibits hepcidin synthesis, reducing iron sequestration and increasing serum iron levels, contributing to erythropoiesis and potentially mitigating anemia, while also posing a risk of iron overload. Hyperinsulinemia associated with insulin resistance further decreases hepcidin levels, enhancing dietary iron absorption and increasing serum iron levels. Despite the chronic low-grade inflammation typical in PCOS, which usually increases hepcidin levels, the inflammation may not be sufficient to override the suppressive effects of hyperandrogenism and hyperinsulinemia on hepcidin expression. Oligomenorrhea or amenorrhea in PCOS leads to reduced menstrual blood loss, contributing to iron retention and further influencing hepcidin regulation. Genetic and epigenetic factors also significantly impact hepcidin expression and iron metabolism in PCOS.

Polycystic ovary syndrome (PCOS) hepcidin iron metabolism hormonal dysregulation insulin resistance hyperandrogenism iron overload

References (27)

  1. 1 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [DOI]
  2. 2 Iron homeostasis in host defence and inflammation [DOI]
  3. 3 The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review [DOI]
  4. 4 Update on PCOS: Consequences, Challenges, and Guiding Treatment [DOI]
  5. 5 Hepcidin and Its Role in Regulating Systemic Iron Metabolism [DOI]
  6. 6 Hepcidin and the BMP-SMAD pathway: An unexpected liaison [DOI]
  7. 7 Hepcidin Therapeutics [DOI]
  8. 8 Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review [DOI]
  9. 9 Hepcidin: A novel peptide hormone regulating iron metabolism [DOI]
  10. 10 Role of Decreased Circulating Hepcidin Concentrations in the Iron Excess of Women with the Polycystic Ovary Syndrome [DOI]
  11. 11 Prevalence of PCOS with Associated Symptoms and Complications at Tertiary Care Hospital of Karachi [DOI]
  12. 12 Polycystic Ovary Syndrome as a Paradigm for Prehypertension, Prediabetes, and Preobesity [DOI]
  13. 13 Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome [DOI]
  14. 14 The Ferritin, Hepcidin and Cytokines Link in the Diagnoses of Iron Deficiency Anaemia during Pregnancy: A Review [DOI]
  15. 15 Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues [DOI]
  16. 16 Iron disorders and hepcidin [DOI]
  17. 17 miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis [DOI]
  18. 18 Key signalling pathways underlying the aetiology of polycystic ovary syndrome [DOI]
  19. 19 Evaluation of serum hepcidin and iron levels in patients with PCOS: a case-control study [DOI]
  20. 20 A Study to Evaluate the Knowledge and Attitude Regarding Polycystic Ovarian Syndrome among Adolescent Girls in Selected Higher Secondary Schools at Trivandrum with a View to Develop a Self-instructional Module [DOI]
  21. 21 The Association of Serum Hepcidin Levels and Insulin Resistance in PCOS Patients: A Case-Control Study.
  22. 22 ALTERED LEVELS OF ANTI-MULLERIAN HORMONE AND HEPCIDIN AS POTENTIAL BIOMARKERS FOR POLYCYSTIC OVARY SYNDROME.
  23. 23 Testosterone Suppresses Hepcidin in Men: A Potential Mechanism of Testosterone-Induced Erythrocytosis. [DOI]
  24. 24 Study of Hepcidin and Many Physiological and Hematological Parameters in Women with Polycystic Ovary in Kirkuk City
  25. 25 Iron Metabolism: Hepcidin [DOI]
  26. 26 Classification and Laboratory Evaluation of Anemia [DOI]
  27. 27 A Study of the Etiology, contributory factors and correlation of the clinical and laboratory profiles of anemia in elderly patients presenting at a tertiary hospital in rural South India

Cited by 6

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

60

Page views

0

PDF downloads

22

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.